Platelet-Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies

Table 1

Shown are the patient characteristics for both cohorts.

	ACP/PRP		Control (no ACP/PRP)		value
	No.	%	No.	%
Patients (total )	82		81
Breast-conserving therapy	67	81.7	58	71.6
Mastectomy	15	18.3	23	28.4	0.18
Smoking	11	13.4	9	11.1
Radiation	61	74.4	33	40.7
Chemotherapy	18	22.0	22	27.2
Hormone therapy	72	87.8	71	87.7
Average age					0.13
Range	37-79		36-82
Average BMI (kg/m^2)					0.03
Range	17.6-35		17.9-40.5
Postmenopausal	53	64.6	56	69.1

All percentage data was calculated excluding the missing data (smoking: ACP , no ACP ; Rtx: ACP , no ACP ; Ctx: ACP , no ACP ; hormone therapy: ACP , no ACP ; BMI: ACP , no ACP ).